Quarterly report · Q2
3154.TEDINET S100RJV3
Period2021-07-01 → 2021-12-31
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100NCZC.
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥112.3bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥213.3bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2020-07-01 → 2020-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-07-01 → 2020-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-07-01 → 2020-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥952m | 2020-07-01 → 2020-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Net income | ¥952m | 2020-07-01 → 2020-12-31 | Cons. | Profit loss |
| Total assets | ¥95.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥84.5bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥86.2bn | at 2020-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥78.1bn | at 2021-12-31 | Cons. | Liabilities |
| Total liabilities | ¥68.6bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.2bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.8bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥14.7bn | at 2020-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.7bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.6bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.6bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.0bn | at 2020-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥3.5bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥554m | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.4bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.0bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥65.37 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.93 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.69 | 2020-07-01 → 2020-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.4 | 2020-10-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥65.34 | 2021-07-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.59 | 2020-07-01 → 2020-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 18.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.0% | at 2020-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | −¥3.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥109.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥109.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥4.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥278m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-12-31 | ¥112.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-12-31 | ¥112.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-12-31 | ¥5.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2020-12-31 | −¥2.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2020-07-01 → 2020-12-31 | ¥99.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2020-07-01 → 2020-12-31 | ¥99.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2020-07-01 → 2020-12-31 | ¥3.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2020-07-01 → 2020-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2020-07-01 → 2020-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2020-07-01 → 2020-12-31 | ¥358m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2020-12-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2020-12-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2020-12-31 | ¥4.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Extraordinary loss | Prior1YTDDuration | 334000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 3348000 | JPY |
| Income before income taxes | Prior1YTDDuration | 1457434000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1928790000 | JPY |
| Income taxes current | Prior1YTDDuration | 360383000 | JPY |
| Income taxes current | CurrentYTDDuration | 527344000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 145089000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -28416000 | JPY |
| Income taxes | Prior1YTDDuration | 505473000 | JPY |
| Income taxes | CurrentYTDDuration | 498927000 | JPY |
| Profit loss | Prior1YTDDuration | 951961000 | JPY |
| Profit loss | CurrentYTDDuration | 1429862000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 951961000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 1429862000 | JPY |
| Profit loss | Prior1YTDDuration | 951961000 | JPY |
| Profit loss | CurrentYTDDuration | 1429862000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 139780000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 233399000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 7644000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 8391000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 147424000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 241790000 | JPY |
| Comprehensive income | Prior1YTDDuration | 1099385000 | JPY |
| Comprehensive income | CurrentYTDDuration | 1671653000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 1099385000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 1671653000 | JPY |
| Income before income taxes | Prior1YTDDuration | 1457434000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1928790000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 321956000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 391172000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 97299000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 103319000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 59565000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 37743000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -20754000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -9759000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -20273000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -13938000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in provision for directors bonuses ope cf | CurrentYTDDuration | 21350000 | JPY |
| Increase decrease in provision for share based compensation ope cf | Prior1YTDDuration | 4466000 | JPY |
| Increase decrease in provision for share based compensation ope cf | CurrentYTDDuration | -139459000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -21352000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -30537000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 26214000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 31399000 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | － | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | 1062000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | -3603000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -3905000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |